What is the projected market valuation for the US lactate dehydrogenase-test market in 2035?

The projected market valuation for the US lactate dehydrogenase-test market in 2035 is $287.3 Million. Read More

What was the market valuation for the US lactate dehydrogenase-test market in 2024?

The market valuation for the US lactate dehydrogenase-test market in 2024 was $168.0 Million. Read More

What is the expected CAGR for the US lactate dehydrogenase-test market during the forecast period 2025 - 2035?

The expected CAGR for the US lactate dehydrogenase-test market during the forecast period 2025 - 2035 is 5.0%. Read More

Which companies are considered key players in the US lactate dehydrogenase-test market?

Key players in the US lactate dehydrogenase-test market include Roche Diagnostics, Abbott Laboratories, Siemens Healthineers, and Thermo Fisher Scientific. Read More

What segment had the highest valuation in the application category for the US lactate dehydrogenase-test market?

In the application category, the Disease Diagnosis segment had the highest valuation, reaching $170.0 Million. Read More

What is the projected valuation for the Clinical Research segment by 2035?

The projected valuation for the Clinical Research segment by 2035 is $70.0 Million. Read More

Which test type is expected to show the highest growth in the US lactate dehydrogenase-test market?

The Immunoassays test type is expected to show the highest growth, with a projected valuation of $100.0 Million by 2035. Read More

What is the expected valuation for hospitals as an end-use segment by 2035?

The expected valuation for hospitals as an end-use segment by 2035 is $135.0 Million. Read More

Which technology segment is projected to reach $102.3 Million by 2035?

The Biosensors technology segment is projected to reach $102.3 Million by 2035. Read More

How does the market valuation for the US lactate dehydrogenase-test market in 2024 compare to the projected valuation in 2035?

The market valuation for the US lactate dehydrogenase-test market in 2024 was $168.0 Million, which is significantly lower than the projected $287.3 Million in 2035. Read More

US Lactate Dehydrogenase Test Market

ID: MRFR/LS/17858-HCR

100 Pages

Satyendra Maurya

Last Updated: May 13, 2026

United States Lactate Dehydrogenase Test Market Research Report By End-Use (Hospitals, Diagnostic Laboratories ,Research Institutes) By Test Type (Enzymatic Tests, Immunoassays, Biosensors) By Technology (Colorimetric, Fluorometric, Chemiluminescent) By Application (Disease Diagnosis, Clinical Research, Drug Development) - Growth & Industry Forecast 2025 To 2035

US Lactate Dehydrogenase Test Market

Market Size

Forecast Period2025 - 2035

CAGR (2025 - 2035)5.0%

2024 Market Size$ 168 Million

2025 Market Size$ 176.4 Million

2035 Market Size$ 287.3 Million

Key Players

Roche Diagnostics

Abbott Laboratories

Siemens Healthineers

Thermo Fisher Scientific

Danaher Corporation

Bio-Rad Laboratories

Trends

Technological Advancements in Testing
Increased Focus on Preventive Healthcare
Rising Incidence of Chronic Diseases

Opportunities

Growing Demand for Diagnostic Testing
Expansion of Healthcare Infrastructure
Technological Innovations in Testing Methods

Summary Table of Contents Segmentation Download PDF

Certified Researchers

Customize Report

SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS |
1. 1.1 EXECUTIVE SUMMARY | |
  1. 1.1.1 Market Overview | |
  2. 1.1.2 Key Findings | |
  3. 1.1.3 Market Segmentation | |
  4. 1.1.4 Competitive Landscape | |
  5. 1.1.5 Challenges and Opportunities | |
  6. 1.1.6 Future Outlook 2
SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE |
1. 2.1 MARKET INTRODUCTION | |
  1. 2.1.1 Definition | |
  2. 2.1.2 Scope of the study | | |
    1. 2.1.2.1 Research Objective | | |
    2. 2.1.2.2 Assumption | | |
    3. 2.1.2.3 Limitations |
2. 2.2 RESEARCH METHODOLOGY | |
  1. 2.2.1 Overview | |
  2. 2.2.2 Data Mining | |
  3. 2.2.3 Secondary Research | |
  4. 2.2.4 Primary Research | | |
    1. 2.2.4.1 Primary Interviews and Information Gathering Process | | |
    2. 2.2.4.2 Breakdown of Primary Respondents | |
  5. 2.2.5 Forecasting Model | |
  6. 2.2.6 Market Size Estimation | | |
    1. 2.2.6.1 Bottom-Up Approach | | |
    2. 2.2.6.2 Top-Down Approach | |
  7. 2.2.7 Data Triangulation | |
  8. 2.2.8 Validation 3
SECTION III: QUALITATIVE ANALYSIS |
1. 3.1 MARKET DYNAMICS | |
  1. 3.1.1 Overview | |
  2. 3.1.2 Drivers | |
  3. 3.1.3 Restraints | |
  4. 3.1.4 Opportunities |
2. 3.2 MARKET FACTOR ANALYSIS | |
  1. 3.2.1 Value chain Analysis | |
  2. 3.2.2 Porter's Five Forces Analysis | | |
    1. 3.2.2.1 Bargaining Power of Suppliers | | |
    2. 3.2.2.2 Bargaining Power of Buyers | | |
    3. 3.2.2.3 Threat of New Entrants | | |
    4. 3.2.2.4 Threat of Substitutes | | |
    5. 3.2.2.5 Intensity of Rivalry | |
  3. 3.2.3 COVID-19 Impact Analysis | | |
    1. 3.2.3.1 Market Impact Analysis | | |
    2. 3.2.3.2 Regional Impact | | |
    3. 3.2.3.3 Opportunity and Threat Analysis 4
SECTION IV: QUANTITATIVE ANALYSIS |
1. 4.1 Healthcare, BY Application (USD Million) | |
  1. 4.1.1 Disease Diagnosis | |
  2. 4.1.2 Clinical Research | |
  3. 4.1.3 Drug Development |
2. 4.2 Healthcare, BY Test Type (USD Million) | |
  1. 4.2.1 Enzymatic Tests | |
  2. 4.2.2 Immunoassays | |
  3. 4.2.3 Biosensors |
3. 4.3 Healthcare, BY End-Use (USD Million) | |
  1. 4.3.1 Hospitals | |
  2. 4.3.2 Diagnostic Laboratories | |
  3. 4.3.3 Research Institutes |
4. 4.4 Healthcare, BY Technology (USD Million) | |
  1. 4.4.1 Colorimetric | |
  2. 4.4.2 Fluorometric | |
  3. 4.4.3 Chemiluminescent 5
SECTION V: COMPETITIVE ANALYSIS |
1. 5.1 Competitive Landscape | |
  1. 5.1.1 Overview | |
  2. 5.1.2 Competitive Analysis | |
  3. 5.1.3 Market share Analysis | |
  4. 5.1.4 Major Growth Strategy in the Healthcare | |
  5. 5.1.5 Competitive Benchmarking | |
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare | |
  7. 5.1.7 Key developments and growth strategies | | |
    1. 5.1.7.1 New Product Launch/Service Deployment | | |
    2. 5.1.7.2 Merger & Acquisitions | | |
    3. 5.1.7.3 Joint Ventures | |
  8. 5.1.8 Major Players Financial Matrix | | |
    1. 5.1.8.1 Sales and Operating Income | | |
    2. 5.1.8.2 Major Players R&D Expenditure. 2023 |
2. 5.2 Company Profiles | |
  1. 5.2.1 Roche Diagnostics (CH) | | |
    1. 5.2.1.1 Financial Overview | | |
    2. 5.2.1.2 Products Offered | | |
    3. 5.2.1.3 Key Developments | | |
    4. 5.2.1.4 SWOT Analysis | | |
    5. 5.2.1.5 Key Strategies | |
  2. 5.2.2 Abbott Laboratories (US) | | |
    1. 5.2.2.1 Financial Overview | | |
    2. 5.2.2.2 Products Offered | | |
    3. 5.2.2.3 Key Developments | | |
    4. 5.2.2.4 SWOT Analysis | | |
    5. 5.2.2.5 Key Strategies | |
  3. 5.2.3 Siemens Healthineers (DE) | | |
    1. 5.2.3.1 Financial Overview | | |
    2. 5.2.3.2 Products Offered | | |
    3. 5.2.3.3 Key Developments | | |
    4. 5.2.3.4 SWOT Analysis | | |
    5. 5.2.3.5 Key Strategies | |
  4. 5.2.4 Thermo Fisher Scientific (US) | | |
    1. 5.2.4.1 Financial Overview | | |
    2. 5.2.4.2 Products Offered | | |
    3. 5.2.4.3 Key Developments | | |
    4. 5.2.4.4 SWOT Analysis | | |
    5. 5.2.4.5 Key Strategies | |
  5. 5.2.5 Danaher Corporation (US) | | |
    1. 5.2.5.1 Financial Overview | | |
    2. 5.2.5.2 Products Offered | | |
    3. 5.2.5.3 Key Developments | | |
    4. 5.2.5.4 SWOT Analysis | | |
    5. 5.2.5.5 Key Strategies | |
  6. 5.2.6 Bio-Rad Laboratories (US) | | |
    1. 5.2.6.1 Financial Overview | | |
    2. 5.2.6.2 Products Offered | | |
    3. 5.2.6.3 Key Developments | | |
    4. 5.2.6.4 SWOT Analysis | | |
    5. 5.2.6.5 Key Strategies | |
  7. 5.2.7 Ortho Clinical Diagnostics (US) | | |
    1. 5.2.7.1 Financial Overview | | |
    2. 5.2.7.2 Products Offered | | |
    3. 5.2.7.3 Key Developments | | |
    4. 5.2.7.4 SWOT Analysis | | |
    5. 5.2.7.5 Key Strategies | |
  8. 5.2.8 PerkinElmer (US) | | |
    1. 5.2.8.1 Financial Overview | | |
    2. 5.2.8.2 Products Offered | | |
    3. 5.2.8.3 Key Developments | | |
    4. 5.2.8.4 SWOT Analysis | | |
    5. 5.2.8.5 Key Strategies |
3. 5.3 Appendix | |
  1. 5.3.1 References | |
  2. 5.3.2 Related Reports 6 LIST OF FIGURES |
4. 6.1 MARKET SYNOPSIS |
5. 6.2 US MARKET ANALYSIS BY APPLICATION |
6. 6.3 US MARKET ANALYSIS BY TEST TYPE |
7. 6.4 US MARKET ANALYSIS BY END-USE |
8. 6.5 US MARKET ANALYSIS BY TECHNOLOGY |
9. 6.6 KEY BUYING CRITERIA OF HEALTHCARE |
10. 6.7 RESEARCH PROCESS OF MRFR |
11. 6.8 DRO ANALYSIS OF HEALTHCARE |
12. 6.9 DRIVERS IMPACT ANALYSIS: HEALTHCARE |
13. 6.10 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE |
14. 6.11 SUPPLY / VALUE CHAIN: HEALTHCARE |
15. 6.12 HEALTHCARE, BY APPLICATION, 2024 (% SHARE) |
16. 6.13 HEALTHCARE, BY APPLICATION, 2024 TO 2035 (USD Million) |
17. 6.14 HEALTHCARE, BY TEST TYPE, 2024 (% SHARE) |
18. 6.15 HEALTHCARE, BY TEST TYPE, 2024 TO 2035 (USD Million) |
19. 6.16 HEALTHCARE, BY END-USE, 2024 (% SHARE) |
20. 6.17 HEALTHCARE, BY END-USE, 2024 TO 2035 (USD Million) |
21. 6.18 HEALTHCARE, BY TECHNOLOGY, 2024 (% SHARE) |
22. 6.19 HEALTHCARE, BY TECHNOLOGY, 2024 TO 2035 (USD Million) |
23. 6.20 BENCHMARKING OF MAJOR COMPETITORS 7 LIST OF TABLES |
24. 7.1 LIST OF ASSUMPTIONS | |
  1. 7.1.1 |
25. 7.2 US MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.2.1 BY APPLICATION, 2025-2035 (USD Million) | |
  2. 7.2.2 BY TEST TYPE, 2025-2035 (USD Million) | |
  3. 7.2.3 BY END-USE, 2025-2035 (USD Million) | |
  4. 7.2.4 BY TECHNOLOGY, 2025-2035 (USD Million) |
26. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL | |
  1. 7.3.1 |
27. 7.4 ACQUISITION/PARTNERSHIP | |

Certified Researchers

Customize Report

US Lactate Dehydrogenase Test Market Segmentation

US Lactate Dehydrogenase Test Market By Application (USD Million, 2025-2035)

Disease Diagnosis
Clinical Research
Drug Development

US Lactate Dehydrogenase Test Market By Test Type (USD Million, 2025-2035)

Enzymatic Tests
Immunoassays
Biosensors

US Lactate Dehydrogenase Test Market By End-Use (USD Million, 2025-2035)

Hospitals
Diagnostic Laboratories
Research Institutes

US Lactate Dehydrogenase Test Market By Technology (USD Million, 2025-2035)

Colorimetric
Fluorometric
Chemiluminescent

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”